UroToday - Erectile Dysfunction (ED)

Home

Erectile Dysfunction (ED)

UroToday's Erectile Dysfunction section is a repository of the clinical publications, clinical trials and investigative science pertaining to the diagnosis and treatment of erectile dysfunction. Also available are conference coverage for all timely erectile dysfunction science, audio podcasts and downloadable slides from UroToday's slide library.

Online Urology & Urologic Oncology Journal
Please read about the UroToday International Journal; We welcome submissions year round and are committed to providing fast-tracked, peer reviewed publication.
Kind regards,
Christian Gratzke, MD
Associate Section Editor Erectile Dysfunction
UroToday International Journal

Display

results per page

Results 736 - 750 of 795

<< Start < Prev 41 42 43 44 45 46 47 48 49 50 Next > End >>

Sildenafil Does not Impair Exercise Tolerance in Men with Stable Angina
Thursday, 08 January 2004
NEW YORK (Reuters Health) - Treatment with sildenafil (Viagra), a popular drug for erectile dysfunction (ED), does not adversely affect exercise tolerance in men with chronic stable angina, according to a recent report. In fact, the drug may have some beneficial effects.
read more

Fundoscopic Examination of the Retina May Predict Vascular Abnormalities in Erectile Dysfunction
Monday, 15 December 2003
Erectile dysfunction may be related to generalized atherosclerosis which afflicts the penile vessels. Dr. Y. Kawanishi and his co-workers at Takamatsu, Japan, Red Cross Hospital used fundoscopic evaluation of the retina to detect possible atherosclerosis in a study of 72 men with erectile dysfunction (ED).
read more

Fate of the Retained Reservoir After Replacement of a Three-Piece Penile Implant
Monday, 01 December 2003
Introduction and Objective: Penile implants have been used in the treatment of erectile dysfunction since the early 1970's. During replacement of the implant for malfunction, the penile cylinders and the pump are removed and usually the reservoir is left behind.
read more

New Pharmacological Preparations Offer Hope in Treatment of Erectile Dysfunction (ED)
Monday, 24 November 2003
In their review on the October 2003 British Journal of Urology, Drs. C.V. Hopps and J. P. Mulhall indicate that many new drug formulations offer potential help to patients with ED that may extend beyond what is seen with the present PDE5 type 5 inhibitors (PDE5).
read more

Lilly, Icos Anti-impotence Drug Cialis Gets FDA Approval
Friday, 21 November 2003
WASHINGTON (Reuters) - The U.S. Food and Drug Administration on Friday said it approved Eli Lilly & Co. and Icos Corp.'s anti-impotence drug, Cialis (tadalafil).
read more

Cialis. (tadalafil) Approved by European Commission for the Treatment of Erectile Dysfunction
Wednesday, 19 November 2003
BOTHELL, Wash. and INDIANAPOLIS, Ind. -- Lilly ICOS LLC (NYSE: LLY and NASDAQ: ICOS) announced today that the European Commission has granted a marketing authorization for Cialis. (tadalafil), an oral PDE5 inhibitor for the treatment of erectile dysfunction (ED) for all 15-member states of the European Union.
read more

Erectile Dysfunction as An Early Indicator of Systemic Oxidative Stress and Endothelial Cell Dysfunction
Wednesday, 19 November 2003
Introduction and Objective: Penile erection involves increased arterial inflow and decreased venous outflow secondary to relaxation of smooth muscle both within the wall of the small penile arteries and the corpus cavernosum.
read more

Studies Indicate Patients Prefer Tadalafil, Vardenafil Over Sildenafil
Monday, 17 November 2003
FRANKFURT (Reuters) - Patients with erectile dysfunction prefer rival drugs over the pioneering treatment, Pfizer's Viagra (sildenafil), show two studies to be presented at a meeting of sexual medicine researchers.
read more

Anti-impotence Nasal Spray Shows Promise in Trial
Monday, 03 November 2003
NEW YORK (Reuters) - An experimental anti-impotence nasal spray achieved its primary goals in a mid-stage clinical trial, the drug's maker said on Monday.
read more

Impotence Drug Maker Fights 'Dirty Old Men' Image
Wednesday, 29 October 2003
LONDON (Reuters) -The maker of a new drug for erectile dysfunction said on Wednesday it was backing a controversial photographic exhibition to ensure users are not seen as "dirty old men."
read more

Receptor Gene Plays Key Role in Regulating Puberty
Thursday, 23 October 2003
NEW YORK (Reuters Health) - An intact G protein-coupled receptor gene (GPR54) seems to be necessary for normal puberty to occur in both humans and mice, according to a report published in the October 23rd issue of The New England Journal of Medicine.
read more

New Approaches to Treatment of Chronic Orchialgia Suggested
Tuesday, 14 October 2003
Diagnosis and treatment of chronic orchialgia challenges many urologists. Drs. Masarani and Cox reviewed their approaches in the March issue of British Journal of Urology International.
read more

Lilly, ICOS yet to Provide Data to FDA on Cialis for Erectile Dysfunction
Friday, 10 October 2003
NEW YORK (Reuters) - Eli Lilly and Co. and ICOS Corp. said on Friday they have not yet provided data on their impotence treatment Cialis requested by U.S. regulators, but still expect to launch the Viagra rival in the second half of 2003.
read more

Vardenafil Beats Sildenafil Study
Thursday, 09 October 2003
LONDON (Reuters) - Nearly half of men who did not respond to sildenafil (Viagra) achieved successful sexual intercourse when given Bayer AG and GlaxoSmithKline Plc's rival drug vardenafil (Levitra), researchers said on Thursday.
read more

Other Benign Headache Types Linked to Headache Associated with Sexual Activity
Tuesday, 30 September 2003
NEW YORK (Reuters Health) - Headaches classified by the International Headache Society as "headache with sexual activity (HSA)" commonly occur in patients with histories of other benign headache types.
read more

Focus on Erectile Dysfunction

Focus on Erectile Dysfunction condenses a selection of compelling and relevant science - on topic and chosen by the UroToday.com editorial staff.

Effects of Once-Daily Tadalafil on Erectile Function in Men with Erectile Dysfunction and Signs and Symptoms of Benign Prostatic Hyperplasia

- by Hartmut Porst, MD and Anne M. Wolka, PhD

Erectile Dysfunction Might Be Associated With Chronic Periodontal Disease: Two Ends of the Cardiovascular Spectrum

- by Yehuda Zadik, DMD, MHA

Tadalafil in the Treatment of Erectile Dysfunction

- by Robert M Coward, MD and Culley C Carson III, MD

Alcohol Consumption and Male Erectile Dysfunction: An Unfounded Reputation for Risk?

- by Kew-Kim Chew, MD

Early Endothelial Dysfunction as a Marker of Vasculogenic Erectile Dysfunction in Young Habitual Cannabis Users

- by Antonio Aversa, MD, PhD

Erectile Dysfunction After External Beam Radiotherapy for Prostate Cancer

- by Michael Pinkawa, MD

Erectile aid use by men treated for localized prostate cancer

- by Christopher P. Evans, MD, FACS

Simplified Approach for Correction of Congenital Penile Curvature

- by Tarek Salem, MD, et al.

Biochemical and Microanatomical Mechanism of Erectile Dysfunction

- by Arnold Melman, MD

Vasoactive Intestinal Polypeptide/Phentolamine for Intracavernosal Injection in Erectile Dysfunction

Phosphodiesterase Type 5 Inhibitors in the Management of Erectile Dysfunction Secondary to Treatments for Prostate Cancer: Findings from a Cochrane Systematic Review

Serial prostate biopsies are associated with an increased risk of erectile dysfunction in men with prostate cancer on active surveillance

- by Christian P. Pavlovich, MD, et al.

Chronology of erectile function in patients with early functional erections following radical prostatectomy
- by John P. Mulhall, MD, et al.

Cardiovascular disease risk, vascular health and erectile dysfunction among middle-aged, clinically depressed men
- by Benson M. Hoffman, MD, et al.

Racial disparities in erectile dysfunction among participants in the California men's health study
- by James F. Smith, MD, MS, et al.

2009 update on phosphodiesterase type 5 inhibitor therapy part 2: updates on optimal utilization for sexual concerns and rare toxicities in this class
- by Alan W. Shindel, MD

Persistent erectile dysfunction following radical prostatectomy: The association between nerve-sparing status and the prevalence and chronology of venous leak
- by John P. Mulhall, MD, et al.

Penile rehabilitation and neuromodulation
- by Fernando Facio, MD and Arthur L. Burnett, MD

Toward a new 'EPOCH': Optimising treatment outcomes with phosphodiesterase type 5 inhibitors for erectile dysfunction
- by Gerald Brock, MD, et al.

Erectile Function Recovery Rate after Radical Prostatectomy: A Meta-Analysis
- by John P. Mulhall, MD, et al.

Diabetes, Obesity, and Erectile Dysfunction
- by Ronald Tamler MD, PhD

Recovery of Erectile Function After Radical Prostatectomy is Quantitatively Related to the Response to Intraoperative Cavernous Nerve Stimulation
- by Farhang Rabbani, MD

The impact of preoperative erectile dysfunction on survival after radical prostatectomy
- Session Highlight by Thomas J. Guzzo, MD, MPH from the AUA Mid-Atlantic Section 67th Annual Meeting

Management of post radical prostatectomy erectile dysfunction
- Presented by David P. Wood, MD at the VI Maratona Urológica

Advanced Techniques for Nerve Preservation
- Session Highlight by Ricardo Sånchez-Ortiz, MD from the 4th Annual World Robotic Urology Symposium (WRUS)

Premature Ejaculation: Advances in Definition, Pathophysiology and Pharmacology
- Multimedia Lecture presented by Dana A. Ohl, MD at the 33rd Winter Urologic Forum

Penile Trauma, Peyronie’s Disease and Erectile Dysfunction
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Presented by Arnold Melman, MD at the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Gene Therapy in Erectile Dysfunction
- Podcast of the Presentation by Arnold Melman, MD at the AUA NY Section 2008

Assessment and Treatment of Erectile Function
- Session Highlight by Harris M. Nagler, MD from the AUA NY Section 2008

Penile Prostheses for the Treatment of Erectile Dysfunction
- Session Abstract written by Culley C. Carson, MD from the Masters in Urology 2008

Erectile Dysfunction and the Prostate: What are the Connections?
- Presented by Culley C. Carson, MD at the Masters in Urology 2008

Erectile Dysfunction After Plaque Incision and Grafting: Incidence and Predictors
- Session Highlight by Michael J. Metro, MD from the AUA 2008

Adult Stem Cell Therapy for Erectile Dysfunction
- Session Highlight by Christopher P. Evans, MD, FACS from the AUA 2008